These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9378629)

  • 1. [Treatment of malignant effusions in body cavities].
    Hentrich M; Hartenstein R
    Internist (Berl); 1997 Aug; 38(8):794-804. PubMed ID: 9378629
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment possibilities in malignant pleural and peritoneal effusions and pseudomyxoma peritonei].
    Meerpohl HG; Karck U
    Gynakologe; 1992 Apr; 25(2):89-98. PubMed ID: 1377158
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiac angiosarcoma: A case with bilateral pleural and pericardial effusion.
    Oc M; Farsak B; Arun O; Oc B; Simsek M; Yildirim S
    Heart Surg Forum; 2013 Dec; 16(6):E353-5. PubMed ID: 24505824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracavitary injection of OK-432 for malignant pericardial effusion, a case report.
    Nanjo T
    Radiat Med; 1990; 8(4):155-8. PubMed ID: 2281151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA profiling in serous cavity specimens: Diagnostic challenges and new opportunities.
    Nicolè L; Cappello F; Cappellesso R; VandenBussche CJ; Fassina A
    Cancer Cytopathol; 2019 Aug; 127(8):493-500. PubMed ID: 31154675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant effusions: from diagnosis to biology.
    Davidson B
    Diagn Cytopathol; 2004 Oct; 31(4):246-54. PubMed ID: 15452897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter management of cardiac and pericardial metastatic involvement.
    Galli M; Politi A; Jemoli R; Zerboni S
    G Ital Cardiol; 1998 Jun; 28(6):687-90. PubMed ID: 9672782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The management of malignant pleural and pericardial effusions.
    Fiocco M; Krasna MJ
    Hematol Oncol Clin North Am; 1997 Apr; 11(2):253-65. PubMed ID: 9137969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracavitary administration of interleukin-2 as palliative therapy for neoplastic effusions.
    Lissoni P; Barni S; Ardizzoia A; Paolorossi F; Tisi E; Crispino S; Tancini G
    Tumori; 1992 Apr; 78(2):118-20. PubMed ID: 1523703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and categorization of malignant effusions: A 6-year review from a single academic institution.
    Lew M; Cantley R; Heider A; Jing X
    Diagn Cytopathol; 2021 May; 49(5):615-621. PubMed ID: 32275354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant pericardial diseases: diagnosis and treatment.
    Kralstein J; Frishman WH
    Cardiol Clin; 1987 Nov; 5(4):583-9. PubMed ID: 3135936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serous effusions in malignant lymphomas: a review.
    Das DK
    Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracavitary therapy of neoplastic effusions with cytokines: comparison among interferon alpha, beta and interleukin-2.
    Lissoni P; Barni S; Tancini G; Ardizzoia A; Tisi E; Angeli M; Rizzi A
    Support Care Cancer; 1995 Jan; 3(1):78-80. PubMed ID: 7697307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of malignant effusions on methotrexate disposition.
    Li J; Gwilt P
    Cancer Chemother Pharmacol; 2002 Nov; 50(5):373-82. PubMed ID: 12439595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant effusions and their management.
    Zehner LC; Hoogstraten B
    Semin Oncol Nurs; 1985 Nov; 1(4):259-68. PubMed ID: 3854237
    [No Abstract]   [Full Text] [Related]  

  • 16. Malignant effusive disease of the pleura and pericardium.
    DeCamp MM; Mentzer SJ; Swanson SJ; Sugarbaker DJ
    Chest; 1997 Oct; 112(4 Suppl):291S-295S. PubMed ID: 9337306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunocytochemical identification of carcinomas of unknown primary in serous effusions.
    Pomjanski N; Grote HJ; Doganay P; Schmiemann V; Buckstegge B; Böcking A
    Diagn Cytopathol; 2005 Nov; 33(5):309-15. PubMed ID: 16240395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant pericardial effusions #209.
    Thai V
    J Palliat Med; 2009 Nov; 12(11):1052-3. PubMed ID: 19922003
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined immunotherapy with intracavital injection of activated lymphocytes, monocyte-derived dendritic cells and low-dose OK-432 in patients with malignant effusion.
    Morisaki T; Matsumoto K; Kuroki H; Kubo M; Baba E; Onishi H; Tasaki A; Nakamura M; Inaba S; Katano M
    Anticancer Res; 2003; 23(6a):4459-65. PubMed ID: 14666734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant pericardial effusion secondary to ovarian adenocarcinoma: a case report.
    Micha JP; Goldstein BH; Zusman D; Rettenmaier MA; Epstein HD; Brown JV
    J Reprod Med; 2007 Oct; 52(10):971-3. PubMed ID: 17977179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.